SCHEMBL6972796

SCHEMBL6972796

CC(=O)OCc1cncc(CCl)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP3A4 P08684 1/20 0.41
P2RX7 Q99572 1/20 0.36
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
HTT P42858 2/20 0.35
IDH1 O75874 1/20 0.35
POLB P06746 1/20 0.34
NOTUM Q6P988 2/20 0.34
CA2 P00918 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GFER P55789 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977255 0.84 ALDH1A1 (0.47) ALDH1A1CYP3A4KMT2AMEN1HTT
SCHEMBL6983640 0.84 ALDH1A1 (0.47) ALDH1A1CYP3A4KMT2AMEN1HTT
SCHEMBL28665851 0.83 NQO1 (0.37) ALDH1A1P2RX7KMT2ALMNAMEN1
SCHEMBL2167806 0.82 ALDH1A1 (0.48) ALDH1A1CYP3A4IDH1POLBCA2
Hydrochloric Acid SCHEMBL1532536 0.81 ALDH1A1 (0.47) ALDH1A1CYP3A4IDH1POLBCA2
SCHEMBL6976950 0.81 ALDH1A1 (0.47) ALDH1A1CYP3A4LMNAIDH1POLB
SCHEMBL2903650 0.79 ALDH1A1 (0.46) ALDH1A1CYP3A4MAPTHTTIDH1
SCHEMBL6976946 0.79 ALDH1A1 (0.46) ALDH1A1CYP3A4P2RX7KMT2ALMNA
SCHEMBL16385951 0.78 ALDH1A1 (0.44) ALDH1A1CYP3A4KMT2AMEN1HTT
SCHEMBL20083591 0.77 ALDH1A1 (0.61) ALDH1A1CYP3A4KMT2AHTTIDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed